WO2004074190A1 - Dispositif de traitement de liquide magnetique et utilisations associees - Google Patents

Dispositif de traitement de liquide magnetique et utilisations associees Download PDF

Info

Publication number
WO2004074190A1
WO2004074190A1 PCT/DK2004/000107 DK2004000107W WO2004074190A1 WO 2004074190 A1 WO2004074190 A1 WO 2004074190A1 DK 2004000107 W DK2004000107 W DK 2004000107W WO 2004074190 A1 WO2004074190 A1 WO 2004074190A1
Authority
WO
WIPO (PCT)
Prior art keywords
fluid
magnet
water
strontium
treatment
Prior art date
Application number
PCT/DK2004/000107
Other languages
English (en)
Inventor
John Hvarre
Original Assignee
Hvarre, Laila
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hvarre, Laila filed Critical Hvarre, Laila
Publication of WO2004074190A1 publication Critical patent/WO2004074190A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F1/00—Treatment of water, waste water, or sewage
    • C02F1/48—Treatment of water, waste water, or sewage with magnetic or electric fields
    • C02F1/481—Treatment of water, waste water, or sewage with magnetic or electric fields using permanent magnets
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • A23L5/30—Physical treatment, e.g. electrical or magnetic means, wave energy or irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0004—Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • C—CHEMISTRY; METALLURGY
    • C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F2103/00—Nature of the water, waste water, sewage or sludge to be treated
    • C02F2103/02—Non-contaminated water, e.g. for industrial water supply
    • C02F2103/026—Treating water for medical or cosmetic purposes
    • C—CHEMISTRY; METALLURGY
    • C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F2103/00—Nature of the water, waste water, sewage or sludge to be treated
    • C02F2103/42—Nature of the water, waste water, sewage or sludge to be treated from bathing facilities, e.g. swimming pools

Definitions

  • Magnetic fluid treatment device and uses thereof
  • the present invention relates to a fluid treatment device for subjecting a fluid to at least one magnetic field.
  • the present invention also relates to a fluid obtainable by the treatment with said device, and uses of said fluid.
  • a magnetic water conditioning device consisting of a pair of strontium ferrite magnets, which is placed externally to any non-ferrous pipe or installation through which water flows. This device was developed for the purposes of inhibiting the formation of scale on surfaces contacted by the water.
  • a water treatment device within which at least one of its flow modifying elements is made wholly or partly of a magnetic material, is described in the European Patent EP 0 502 890 Bl and in the Danish Patent DK 166527 Bl .
  • the state of the calcium carbonate is changed and as a result the mouthpiece for a water tapping point is automati- cally kept free of incrustation.
  • magnets are used for forming the magnetic field.
  • magnets made of metal ferrite are described. These magnets consist of a material having the general formula MO * ⁇ Fe 2 0 3 , wherein M typically is barium or strontium, and n has a value of about 6. This type of material is known to yield permanent magnets. The preparation of such strontium ferrite magnets is described in US 4,062,922 and in the Danish patent No. 105349.
  • a method of improving skin conditions by topi- cal administration of a physiologically acceptable substrate that is exposed to a magnetic vector potential field is disclosed in WO 97/44810.
  • the authors of said script believe that the advantageous effect is caused by an increase in proline uptake in human dermal fibroblast cells by contacting the cells with said magnetic treated substrate.
  • the script stipulates that a number of skin conditions may be improved by topical administration of said substrate to the skin.
  • a shower device consisting of annular permanent magnets (having the function of magnetising a magnetite layer) together with Bakuhan- seki (a special stone found in the mountain areas of Japan and China) is used as a purifying function for the removal of chlorine, poisonous heavy metals, organic matter, and bacteria in water.
  • a fluid treatment de- vice comprising magnets made of a material comprising one or more strontium compound (s) and ferrite has very surpris- ingly shown beneficial effects compared to the disclosures in the prior art documents within two specific fields of application.
  • a fluid obtainable by treatment with a device according to the present invention may be used in the preparation of products such as food, beverages, and pharmaceuticals.
  • products such as food, beverages, and pharmaceuticals.
  • a prophylactic or therapeutic reduction of symptoms associated with histamine release is observed.
  • treating a fluid with a device according to the present invention have shown a markedly reduction of heavy metals from said fluid.
  • Histamine is an important protein involved in many allergic reactions. Allergies are caused by an immune response to antigens from generally innocuous substance (i.e. pollen, dust) that comes in contact with lymphocytes specific for that substance. In many cases, the lymphocyte, which is triggered to respond, is a mast cell. For this response to occur, a free- floating IgE (an immunoglobulin associated with allergic response) molecule specific to the antigen must first be attached to cell surface receptors on mast cells. Antigen binding to the mast cell-attached IgE then triggers the mast cell to respond. This response includes the release of histamine.
  • IgE an immunoglobulin associated with allergic response
  • Histamine causes several allergic symptoms. It contributes to an inflammatory response, and it causes constriction of smooth muscle. Histamine can cause inflammation directly as well as indirectly.
  • antihistamines Drugs called antihistamines are frequently used in the treatment of allergies.
  • One effect of antihis- tamines is the inhibition of the histamine-mediated release of inflammatory mediators by leukocytes.
  • Other effects of antihistamine result in neutralization of histamine, preventing it from binding and ac- tivating immune-related cells in the area.
  • exanthema such as eczema, psoriasis exanthema virus infections or fungal infection in the skin or in the mucous membrane can also be related to an increased histamine release from the mast cells.
  • exanthema is extremely annoying for the patient as they itches, forms blisters or scales but also because these symptoms constitute a cosmetic problem.
  • the exanthemas are known to be difficult to treat and the treatments are often long-term. To this should be added that known medicaments for treating these exanthemas are known to involve more or less severe side effects.
  • atopic ec- zemas such as, for instance, infantile eczema, asthma eczema, atopic dermatitis or Prurigo Besnier.
  • the number of persons with atopic eczema is increasing and today about 15% children and youth in the Western World suffer from atopic eczema.
  • the treatment aims at removing the substances or conditions that provoke the exanthema and to relieve the pruritus and the infection condition.
  • the treatment of the exanthema itself often takes place by means of cream containing adrenal cortical hormone in different concentrations. However, treatment is often necessary for a long period of time in order to at least partly eliminate the exanthema.
  • adrenal cortical hormone has often proven only to be effective upon use for a longer period of time, which often involves a number of adverse effects.
  • the skin becomes dry, thin, and brittle.
  • Some people develop allergy to adrenal cor- tical hormone and their eczema is even aggravated.
  • strontium from drinking water binds to the skeleton of human beings and animals.
  • the hardness of the bone structure increases because the presence of strontium in the skeleton increases the uptake of calcium in the bones.
  • an increase in the concentration of strontium in the drinking water would have a beneficial effect on the bone structure.
  • the problem of securing a supply of drinking water free of undesirable contaminants has become particularly acute in the recent years. Such contaminants may include both disease causing organisms, as well as various types of toxic chemicals such as toxic solvents, pesticides residues, complex organic chemicals, and heavy metals. Heavy metal contamination of drinking water supplies has become of particular concern in recent years due to the acceler- ated pace of industrialization.
  • Heavy Metals Protocol There is no uniform definition of heavy metals, however in the United Nations Economic Commision for Europe Heavy Metals Protocol are heavy metals defined as "... those metals or, in some cases, metalloids which are stable and have a density greater than 4.5 g/cm 3 and their compounds.” The same definition is used for this application.
  • Contamination of drinking water with heavy met- als such as lead, cadmium, and mercury is known to cause widespread detrimental effects on the population serviced by the drinking water supply, such detrimental effects including long term, crippling nerve, muscle and bone degeneration, impaired liver and kidney function, and a metal retardation and delayed development in young- children.
  • Mercury is a known neurotoxin and lead is both teratogenic and mutagenic .
  • a corollary problem is that of removing heavy metals from wastewater.
  • Today various methods for removing heavy metal contaminants from drinking water and wastewater have been devised. Most practical systems involving ion exchange resins or membrane separation systems are prohibitive due to their high costs .
  • Activated carbon has long been known as a useful material for filtering and purifying drinking water. " It is .particularly useful for removing ' such contaminants as chlorine and organic compounds from wa- ter supplies.
  • the present invention relates to a fluid treatment device for subjecting a fluid to at least one magnetic field, a fluid obtainable by the treatment with said device, and uses of said fluid.
  • Said fluid may be used in the preparation of products for oral administration for the prophylactic and therapeutic reduction of symptoms associated with histamine release in dermal or mucous tissue.
  • the fluid may be used in the preparation of a cream or ointment for topical administration.
  • the patients may be treated simply by bathing in the fluid according to the present invention.
  • One aspect of the present invention relates to a fluid treatment device for subjecting a fluid to at least one magnetic field, wherein the magnetic field is formed by at least one magnet made of a material comprising one or more strontium compound (s) and fer- rite. . .
  • the magnetic field is formed by at least one magnet made of a material comprising one or more strontium compound (s) and ferrite, as it has been found that magnets comprising strontium, and especially magnets comprising strontium carbonate, are extremely effective for the fields of application according to the present invention.
  • one or more strontium compound (s) as used herein is meant any chemical composition comprising strontium either as an atom or as an ion.
  • a part, or all, of the strontium present in the magnet is strontium carbonate.
  • the magnet comprises from 2% to 20%, even more preferred from 5% to 15%, strontium carbonate based on the total weight of the magnet .
  • the magnet comprises 13.8% strontium carbonate based on the total weight of the magnet .
  • the molar ratio of strontium to ferrite is at least 1:10, preferably at least 1:7 and especially at least 1:5.
  • the at least one magnet used in the present invention is characterised by physical constants such as coercive force, energy product, and permanent remanence.
  • coercive force is defined as the demagnetising force necessary to reduce observed induction to zero after the magnet has previously been brought to saturation
  • energy product indicates the energy that a magnetic material can supply to an external magnetic circuit when operating at any point on its demagneti- sation curve
  • the term “remanence” is defined as the magnetic induction that remains in a magnetic circuit after removal of an applied magnetising force .
  • the magnet presents a coercive force of at least 200 kA/m at 25°C and an energy product of at least 20 kJ/m 3 , or more preferred at least 40 kJ/m 3 , and a permanent remanence of at least 0.42 Weber/m 2 , preferably 0.38 Weber/m 2 .
  • the magnet is disposed substantially transversely to the flow direction of the fluid. If the magnet comprises an aperture, which extends through the magnet, this aperture will provide a passageway for the fluid. This means that when the device is placed, for instance, in a water pipe in connection with a water supply, this construction ensures that the presence of the magnet in the pipe will have almost no impact on the water flow rate.
  • the device according to the invention may, if desired, comprise a number of magnets placed in series.
  • the magnets are preferably arranged in such a way that the poles at abutting magnet ends repel one another.
  • the opening extending in the individual magnets form together an axially extending passageway for the fluid.
  • a good effect may be achieved when several magnets are arranged with a mutual spacing as this promotes a turbulent flow, which in some instances sur- prisingly can assist in making the fluid more useful as a medicament for reducing symptoms associated with histamine release in dermal or mucous tissue. Furthermore, this promoting of a turbulent flow assists in lowering the concentration of the heavy metals in the fluid.
  • the device according to the invention may, for instance, be constructed as a fluid tapping point, preferably in form of a water tap, a shower, a shower pipe, a mixing tap or a tapping point for a drinking water dispenser.
  • a fluid tapping point preferably in form of a water tap, a shower, a shower pipe, a mixing tap or a tapping point for a drinking water dispenser.
  • the device is a part of the pipeline supplying water to the tapping points. If, for instance, the device is inserted in combination with the stopcock of a house, this will ensure that the water is treated before the water enters the water distribution pipes, whereby only one device instead of several devices at each tapping point is required. In such cases, it may be necessary to provide a larger magnetic field.
  • the device may be inserted at any point in the water distribution pipes, for instance, if it is desired that only part of the water in the distribution pipe should be treated or if the water should be treated differently at another point . In any case, the person skilled in the art would understand, based on conventional technology, how the device according to the invention could be constructed.
  • a fluid obtainable by the treatment with the device according to the present invention constitutes a second aspect of the present invention.
  • Yet another aspect of the present invention relates to the use of said fluid for the preparation of food, beverages, and pharmaceuticals for human beings and animals.
  • the term “food, beverages, and phamaceuti- cals” as used herein is meant any eatable or drinkable product, which ' during its preparation has been added a fluid obtainable by the treatment with the device according to the present invention.
  • the product may be the fluid according to the invention itself.
  • Other preferred examples of such products include dietary supplements, and juice.
  • the product itself may be subjected to the magnetic treatment according to the invention.
  • the present inventor has found that when the fluid according to the invention is applied to the patient's tissue, the above-mentioned symptoms, such as itching and smarting, were not only relieved, but in some cases they disappeared completely, as long as the patient used the fluid.
  • the fluid is preferably water and the magnetic field is applied to the water in connection with the water supplying system, either before or at the tapping point.
  • water may be tapped either for the purpose of drinking or for the purpose of bathing in order to treat symptoms associated with histamine re- lease such as itching, smarting, redness, blisters, scales, or chaps in dermal or mucous tissue.
  • a low C0 2 concentration causes mast cells to release histamine and other mediators increases the inflammatory response, noted as swelling, erythema and purities on the skin surface.
  • the magnetic treatment of the water allows the C0 2 to stay dissolved in water. Furthermore, the magnetic treatment ensures that the CaC0 3 is dissolved, and as a result the concentration of C0 2 in the water is further increased.
  • the present invention provides a device and a process for reducing the concentra- tions of heavy metals in water supplies. Such a process is easy to construct, simple to operate and utilizes relatively inexpensive materials.
  • heavy metal as used herein is defined as metals or, in some cases, metalloids, which are stable and have a density greater than 4.5 g/cm 3 and their compounds .
  • the fluid is subjected to at least one magnetic field. It has surprisingly been demonstrated that the concentration of heavy metals in fluids are reduced after having been subjected to a magnetic field.
  • This magnetic field is preferably formed by magnets, which comprises strontium carbonate and fer- rite, as it has been found that said magnets most efficiently reduces the concentration of heavy metals and suspended solids from aqueous media.
  • said magnets may contain one or more atoms capable of be- ing replaced by other metal ions. These characteristics, together with the strongly magnetic character of ferrite, make them particularly suited to applications associated, for instance, with wastewater de- contamination.
  • Each patient determined the intensity of the symptoms and placed it on a scale of 0 (absent) to 3 (severe) , in a manner similar to the SCORAD Index.
  • the patients were instructed to take a bath in the respective fluid at 37°C temperature and a pH of 5.4 for 10 minutes at least once a day. Furthermore, the affected areas had to be intensively exposed to the respective fluid for at least 1 minute.
  • the magnet used in the tapping point according to the invention has the following composition and characteristics as described in Table I.
  • the fluid according to the invention can be used for treating symptoms associated with histamine release in dermal or mucous tissue.
  • Water samples of each 100 ml were placed in plastic bottles at room temperature.
  • the water samples were Milli-Q water with a resistance of 20 M ⁇ and common tap water from Denmark, respectively.
  • the elements were measured in the sample using
  • ICP- MS Inductively Coupled Plasma - Mass Spectrometry
  • the concentration is measured as the average concentration from 3 samples.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Hematology (AREA)
  • Hydrology & Water Resources (AREA)
  • Environmental & Geological Engineering (AREA)
  • Water Supply & Treatment (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne un dispositif de traitement de liquide permettant de soumettre un liquide à au moins un champ magnétique. Cette invention a aussi trait à un liquide obtenu par traitement au moyen dudit dispositif et à des utilisations du liquide et du dispositif. L'utilisation du liquide comprend la préparation d'un produit destiné à la diminution prophylactique et thérapeutique des symptômes liés à la libération d'histamine, et le dispositif est utilisé pour diminuer la concentration de métaux lourds dans des liquides traversant le dispositif.
PCT/DK2004/000107 2003-02-18 2004-02-18 Dispositif de traitement de liquide magnetique et utilisations associees WO2004074190A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200300247 2003-02-18
DKPA200300247 2003-02-18

Publications (1)

Publication Number Publication Date
WO2004074190A1 true WO2004074190A1 (fr) 2004-09-02

Family

ID=32892819

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DK2004/000107 WO2004074190A1 (fr) 2003-02-18 2004-02-18 Dispositif de traitement de liquide magnetique et utilisations associees

Country Status (1)

Country Link
WO (1) WO2004074190A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106174387A (zh) * 2016-07-12 2016-12-07 中国海洋大学 一种复合海肠调味料及其制备方法和应用

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2648232A1 (de) * 1976-10-25 1978-04-27 Leopold Ch Schader Dauermagnetsystem zur beeinflussung biologischer vorgaenge
WO1985003649A1 (fr) * 1984-02-21 1985-08-29 Kronenberg Klaus J Procede et appareil de conditionnement d'un fluide magnetique resonnant
DE29612736U1 (de) * 1996-07-23 1996-10-10 Bildner, Karlheinz, Dipl.-Ing., 63589 Linsengericht Wasseraufbereitungs-Anlage mit flexiblen Permanentmagneten
US5813557A (en) * 1994-12-27 1998-09-29 Oratz; Ben Magnetized fluid vessel
WO2000006501A1 (fr) * 1998-07-27 2000-02-10 John Nikolaj Hvarre Dispositif et procede de traitement de l'eau du robinet et d'eau potable

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2648232A1 (de) * 1976-10-25 1978-04-27 Leopold Ch Schader Dauermagnetsystem zur beeinflussung biologischer vorgaenge
WO1985003649A1 (fr) * 1984-02-21 1985-08-29 Kronenberg Klaus J Procede et appareil de conditionnement d'un fluide magnetique resonnant
US5813557A (en) * 1994-12-27 1998-09-29 Oratz; Ben Magnetized fluid vessel
DE29612736U1 (de) * 1996-07-23 1996-10-10 Bildner, Karlheinz, Dipl.-Ing., 63589 Linsengericht Wasseraufbereitungs-Anlage mit flexiblen Permanentmagneten
WO2000006501A1 (fr) * 1998-07-27 2000-02-10 John Nikolaj Hvarre Dispositif et procede de traitement de l'eau du robinet et d'eau potable

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
FRED RINKER: "Magnetic water", INVISIBLE FORCE: TRADITIONAL MAGNETIC THERAPY, 31 December 1997 (1997-12-31), pages 103 - 108, XP002958542 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106174387A (zh) * 2016-07-12 2016-12-07 中国海洋大学 一种复合海肠调味料及其制备方法和应用

Similar Documents

Publication Publication Date Title
Varkey Purification of river water using Moringa Oleifera seed and copper for point-of-use household application
US20040202728A1 (en) Method for the destruction of oocysts
KR20070020340A (ko) 천연추출물질과 기능성워터를 구성요소로 포함하여 제조된천연조성물 및 기능성식수
TAKANAMI et al. Antiviral drugs zanamivir and oseltamivir found in wastewater and surface water in Osaka, Japan
Kihampa et al. Performance of Solanum incunum Linnaeus as natural coagulant and disinfectant for drinking water
JP2009027957A (ja) 体内浄化用清涼飲料水および体内浄化用清涼飲料水の製造方法
WO2004074190A1 (fr) Dispositif de traitement de liquide magnetique et utilisations associees
Griffini et al. Removal of pesticides during the drinking water treatment process at Florence water supply, Italy
Lu et al. Review of swimming-associated Cryptosporidiosis and Cryptosporidium oocysts removals from swimming pools
CN101428893B (zh) 麦饭石饮用水的制备方法
Isirima et al. Comparative Cough Suppression of Chitosan Crab Extract of Uca tangeri and Dihydrocodeine
US6652747B2 (en) Device and a method for the treatment of tap water and drinking water
CN102511500B (zh) 一种抑菌剂及其制备方法和净水装置
CN1084139A (zh) 深度净水剂
CN1218009A (zh) 一种含银离子活性水及其制备方法
CN1485283A (zh) 麦饭石矿化水的制造方法
AU2002254803B2 (en) Method for the destruction of oocysts
CN2093688U (zh) 三化饮用水处理器
US5792370A (en) Chemical method for destruction of pathogenic organisms in water
Okunlola et al. Effect of Carica papaya materials on microbial and physicochemical qualities of river, stream and pond water
Chang et al. Removal of selected pharmaceuticals using Octolig®, a supported chelating agent
CN202096822U (zh) 具能量信息的多重过滤装置
CN105883990A (zh) 一种环保型净水消毒泡腾片剂及其制备方法
Roesky et al. Group 13 Chemistry II: Biological Aspects of Aluminum
EP0743015A1 (fr) Thé pour la santé et procédé pour sa préparation

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase